Neuren Pharmaceuticals Limited (ASX:NEU) is developing new therapies for highly debilitating neuro-developmental disorders that emerge in early childhood and are characterised by impaired connections and signalling between brain cells. Neuren's deep expertise in neuro-developmental disorder therapy has been accumulated over years of clinical development.

